Cancer Immunology – News and Features
Article
The Importance of LGBTQIA+ Representation in Science
Dr. David Bending discusses his research interests and experience as an LGBTQIA+ immunologist. He offers advice for others beginning a career in STEMM and highlights the importance of LGBTQIA+ representation.
News
Combination of Existing Drugs Could Improve Breast Cancer Therapy
The combination of standard-of-care chemotherapy, a checkpoint inhibitor and a non-steroidal anti-inflammatory medication slowed the progression of cancer and reduced tumor growth in animal models.
Article
Dr. Jay Mandula Explores the Importance of Diversity in Cancer Research
In this interview, Jay Mandula describes his work in immuno-oncology, the challenges of being transgender in Florida and how increased visibility of LGBTQIA+ scientists can impact STEMM.
News
Immune Cells' Dual Pathways to Produce Acetyl-CoA Could Boost Immunotherapy
A study from Van Andel Institute reveals that immune cells use two pathways, ACLY and ACSS2, to produce acetyl-CoA, an essential metabolite for fighting infection and cancer. These findings highlight the interplay between metabolism and epigenetics.
News
Potential Immunotherapy Treatment Pathway for Bladder Cancer Identified
University of Queensland research could lead to a more effective immunotherapy treatment against bladder cancer. A team has found the mechanism used by bladder cancer to suppress the immune system’s natural killer (NK) cells.
News
Light Can Control White Blood Cells’ Appetite for Cancer Cells
A light-controlled "appetizer" that stimulates macrophages can increase their appetite for cancer cells, finds a new study.
News
Enhancing Immune Cells To Target Pediatric Brain Cancer
Florida State University researchers are giving oncologists another tool in their fight against pediatric brain cancer. Researchers showed the possibility of enhancing natural killer immune cells to improve their ability to attack.
News
How the BCG Vaccine Uses Macrophages to Fight Bladder Cancer
This may come as a surprise, but the BCG vaccine against tuberculosis is the oldest immunotherapy against cancer. Now, a team from the Champalimaud Foundation, in Lisbon, has found the first steps of its action to destroy cancer cells.
Article
Discovery of Key Genetic Driver in Neuroblastoma Paves Way to New Therapeutic Approaches
Scientists have taken a fresh approach to finding a way to target neuroblastoma, the most common solid tumor of infancy. Their novel gene target could offer hope for finding alternative treatments with fewer long-term side effects.
News
Drug Bypasses Suppressive Immune Cells To Unleash Immunotherapy
Immunobiologists found that a subset of immune cells that normally puts the brakes on the immune system to prevent it from attacking the body’s healthy cells inadvertently also dampens cancer immunotherapy.
Advertisement